Contrast Enhancement on Coronary Computed Tomographic Angiography

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT02462044

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02462044
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02462044. Randomized; double masking; primary purpose diagnostic. Start 2014-08 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Contrast Enhancement on Coronary Computed Tomographic Angiography
Acronym
EICAR
Condition
Coronary Stenosis
Intervention (Drug)
240 mg Iodine
Intervention (Drug)
300 mg Iodine
Intervention (Drug)
370 mg Iodine
Lead sponsor
Maastricht University Medical Center (class: other)
Collaborator
Bayer (class: industry)

Record details

Record id
cardio:ct-nct02462044
Content hash
caa36970291e3f896678ec6ec58430f15af52173613b949831dfbf6635e66a42